Jacek Spławiński
- Pharmacology top 5%
- Molecular Biology
- Biochemistry top 2%
- Physiology
- Cardiology and Cardiovascular Medicine
- Co-authors
- Alan S. NiesJohn A. OatesSylwia FlisJ. TannenbaumAgnieszka GnyszkaRyszard KorbutJ A OatesR.J. Gryglewski
- Topics
- Inflammatory mediators and NSAID effects (16 papers)Eicosanoids and Hypertension Pharmacology (11 papers)Antiplatelet Therapy and Cardiovascular Diseases (7 papers)
- Cited by
- BiochemistryPharmacology
- Journals
- Circulation ResearchBiochemical and Biophysical Research CommunicationsJournal of Allergy and Clinical Immunology
- Partner nations
- PolandUnited StatesNorway
In The Last Decade
Jacek Spławiński
45 papers receiving 620 citations
Peers
Comparison fields: 5 of 102
- Pharmacology 275
- Molecular Biology 195
- Biochemistry 178
- Physiology 122
- Cardiology and Cardiovascular Medicine 109
Countries citing papers authored by Jacek Spławiński
This map shows the geographic impact of Jacek Spławiński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacek Spławiński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacek Spławiński more than expected).
Fields of papers citing papers by Jacek Spławiński
This network shows the impact of papers produced by Jacek Spławiński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacek Spławiński. The network helps show where Jacek Spławiński may publish in the future.
Co-authorship network of co-authors of Jacek Spławiński
This figure shows the co-authorship network connecting the top 25 collaborators of Jacek Spławiński. A scholar is included among the top collaborators of Jacek Spławiński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacek Spławiński. Jacek Spławiński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 33 | |
| 3 | 25 | |
| 4 | 10 | |
| 5 | Antiangiogenic effect of sulindac sulfide could be secondary to induction of apoptosis and cell cycle arrest. | 18 |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 19 | |
| 9 | 11 | |
| 10 | 9 | |
| 11 | 13 | |
| 12 | 2 | |
| 13 | Endogenous mechanisms that regulate prostacyclin release. | 17 |
| 14 | 5 | |
| 15 | 21 | |
| 16 | A new endocrine-like function of lungs: generation of prostacyclin. | 1 |
| 17 | 10 | |
| 18 | 33 | |
| 19 | 116 | |
| 20 | 7 |
About Jacek Spławiński
Jacek Spławiński is a scholar working on Biochemistry, Pharmacology and Pharmacology, having authored 45 papers that have together received 718 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (16 papers), Eicosanoids and Hypertension Pharmacology (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). The work is most often cited by research in Biochemistry (178 citations), Pharmacology (275 citations) and Pharmacology (66 citations). Jacek Spławiński has collaborated with scholars based in Poland, United States and Norway. Frequent co-authors include Alan S. Nies, John A. Oates, Sylwia Flis, J. Tannenbaum, Agnieszka Gnyszka, Ryszard Korbut, J A Oates, R.J. Gryglewski, Z Górka and Gryglewski Rj. Their work appears in journals such as Circulation Research, Biochemical and Biophysical Research Communications and Journal of Allergy and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.